Compound Detail
CHEMBL895
NALBUPHINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314
Basic Information
| ChEMBL ID | CHEMBL895 |
| Name | NALBUPHINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | NETZHAKZCGBWSS-CEDHKZHLSA-N |
| Therapeutic | ✓ Yes |
3
Targets
42
Activities
3
Assay Types
11
PK Parameters
20
Publications
3
Known Names
3
Indications
Molecular Properties
357.4
MW (Da)
1.71
ALogP
5
HBA
3
HBD
73.2
PSA (Ų)
0.75
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1979 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Indications
Pain Delirium Idiopathic Pulmonary Fibrosis
ATC Classification
N02AF02
nalbuphine
Level 1: NERVOUS SYSTEM
Level 2: ANALGESICS
Activity Summary
Ki 19 meas. best 9.05
IC50 13 meas. best 9.0
EC50 10 meas. best 7.85
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Mu-type opioid receptor CHEMBL233 | Ki | 9.05 | 8.6056 | 0.9 | 9 |
| Mu-type opioid receptor CHEMBL233 | IC50 | 9.0 | 7.2178 | 1.0 | 9 |
| Kappa-type opioid receptor CHEMBL237 | Ki | 8.66 | 7.93 | 2.2 | 5 |
| Mu-type opioid receptor CHEMBL233 | EC50 | 7.85 | 7.562 | 14.0 | 5 |
| Kappa-type opioid receptor CHEMBL237 | EC50 | 7.6 | 7.242 | 25.1 | 5 |
| Kappa-type opioid receptor CHEMBL237 | IC50 | 7.08 | 7.02 | 83.0 | 2 |
| Delta-type opioid receptor CHEMBL236 | Ki | 6.62 | 6.408 | 240.0 | 5 |
| Delta-type opioid receptor CHEMBL236 | IC50 | 6.45 | 6.085 | 353.0 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 169.1 | g.hr | Rattus norvegicus |
| AUC | 11.3 | hr.sec | Rattus norvegicus |
| AUC | 175.9 | g.hr | Rattus norvegicus |
| AUC | 16.9 | hr.sec | Rattus norvegicus |
| CL | 22.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 22.0 | mL.min-1.kg-1 | Homo sapiens |
| F | 20.0 | % | Homo sapiens |
| F | 11.0 | % | Homo sapiens |
| Fu | 0.5 | - | Homo sapiens |
| MRT | 3.5 | hr | Homo sapiens |
| T1/2 | 3.7 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine